Mucosa-Associated Lymphoid Tissue Lymphoma in Sjogren's Syndrome: Risks, Management, and Prognosis

Voulgarelis, M; Moutsopoulos, HM

dc.contributor.author	Voulgarelis, M	en
dc.contributor.author	Moutsopoulos, HM	en
dc.date.accessioned	2014-03-01T01:57:28Z
dc.date.available	2014-03-01T01:57:28Z
dc.date.issued	2008	en
dc.identifier.issn	0889-857X	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/28428
dc.subject	Sjogren's syndrome	en
dc.subject	Lymphoma	en
dc.subject	Lymphoproliferation	en
dc.subject	Predictive factors	en
dc.subject	MALT	en
dc.subject	Autoimmunity	en
dc.subject	Marginal zone B-cell lymphoma	en
dc.subject.classification	Rheumatology	en
dc.subject.other	B-CELL LYMPHOMA	en
dc.subject.other	NON-HODGKINS-LYMPHOMA	en
dc.subject.other	GRADE GASTRIC LYMPHOMA	en
dc.subject.other	MALIGNANT-LYMPHOMA	en
dc.subject.other	MALT LYMPHOMA	en
dc.subject.other	MYOEPITHELIAL SIALADENITIS	en
dc.subject.other	RHEUMATIC DISEASES	en
dc.subject.other	CLINICAL ACTIVITY	en
dc.subject.other	LIGHT-CHAINS	en
dc.subject.other	RITUXIMAB	en
dc.title	Mucosa-Associated Lymphoid Tissue Lymphoma in Sjogren's Syndrome: Risks, Management, and Prognosis	en
heal.type	journalArticle	en
heal.language	English	en
heal.publicationDate	2008	en
heal.abstract	Sjogren's syndrome is a chronic inflammatory disease primarily affecting the exocrine glands. Its association with lymphoma is well documented, with salivary extranodal marginal zone lymphomas of the mucosa-associated lymphoid tissue type being the most common and constituting a major disease complication. These neoplasms are antigen-stimulated B-cell lymphomas characterized by localized stage, indolent clinical course, and recurrence in other extranodal sites. This article presents a review of the literature and discusses the clinical, histopathologic, therapeutic, and prognostic aspects of these tumors in Sjogren's syndrome. In addition, it highlights the predictor markers of lymphoma development.	en
heal.publisher	W B SAUNDERS CO-ELSEVIER INC	en
heal.journalName	RHEUMATIC DISEASE CLINICS OF NORTH AMERICA	en
dc.identifier.isi	ISI:000261199800007	en
dc.identifier.volume	34	en
dc.identifier.issue	4	en
dc.identifier.spage	921	en
dc.identifier.epage	+	en